Profile

Cover photo
Cancer Research Institute
411 followers|102,026 views
AboutPostsPhotosVideos

Stream

Pinned
 
FDA Approves PD-1 Immunotherapy for Most Common Type of Lung Cancer 
1
2
Marilyn Manson's profile photo
 
Heard of Rituxin? Dr. Ron Levy helped develop this groundbreaking immunotherapy for lymphoma. This month, he leads our free webinar on treating lymphoma and leukemia with immunotherapy. Join us! http://bit.ly/1PLtrRq
TimeZone (America/Los Angeles). (UTC-11:00) Pacific/Midway, (UTC-11:00) Pacific/Niue, (UTC-11:00) Pacific/Pago Pago, (UTC-11:00) Pacific/Samoa, (UTC-11:00) US/Samoa, (UTC-10:00) America/Adak, (UTC-10:00) America/Atka, (UTC-10:00) Pacific/Honolulu, (UTC-10:00) Pacific/Johnston ...
1
2
Marilyn Manson's profile photo
 
There were 10 new FDA approvals for cancer immunotherapies in 2015. We round them up here:
In 2015, the FDA approved more immunotherapies than in any prior year.
1
1
Add a comment...
 
Recap of the final day of #CICON15, featuring research on preventative cancer vaccines.
1
Add a comment...
 
Recap of Day 2 of our International Cancer Immunotherapy Conference, #CICON15.  
1
Add a comment...
 
"The next ten years will be the best you’ve ever had in this field." Bill Clinton, on immunotherapy at the #CRIGala. More here: http://bit.ly/1Vbby2x
1
Add a comment...
 
We’re pleased to announce our new partnership with Inspire – we’ve joined together to create a peer-to-peer online support community focused on immunotherapy for all types of cancer. Join today: http://bit.ly/InspireCRI
1
Bunmi Tomiwa's profile photo
 
Good work. Need to get in contact with you
Add a comment...
 
“The excitement that we're now seeing in the clinic is phenomenal."— Jill O’Donnell-Tormey, PhD. Our CEO, Dr. O'Donnell-Tormey, spoke with Business Insider’s Lydia Ramsey last month about the past, present and future of cancer immunotherapy.
1
Add a comment...
 
FDA approves combination of checkpoint inhibitors for the treatment of advanced melanoma.
1
Add a comment...
 
Our report from day 3 of #CICON15 features research on determining which patients will respond to cancer #immunotherapy. 
1
Add a comment...
 
Report from Day 1 of our International Cancer Immunotherapy Conference, #CICON15 . 
1
Add a comment...
 
Thrilled that Dr. James P. Allison, director of our Scientific Advisory Council, has won the 2015 Lasker–DeBakey Clinical Medical Research Award. Dr. Allison is being honored for “the discovery and development of a monoclonal antibody therapy that unleashes the immune system to combat cancer.” 
1
Add a comment...
Story
Tagline
The Leader In Immunotherapy
Introduction
The Cancer Research Institute is dedicated to advancing a new class of cancer treatments that enhance the immune system's natural ability to protect us against cancer and infectious diseases.

Mission
To improve patient care by advancing a new class of cancer therapies that mobilize the immune system to treat, control, and prevent cancer. www.cancerresearch.org

Company Overview
The nonprofit leader in advancing immunotherapy to conquer all types of cancer, the Cancer Research Institute supports basic and clinical research through grants and scientific conferences. CRI's basic research and education grants fund predoctoral graduate student training programs, postdoctoral fellowships, and investigator awards. Its clinical programs support coordinated, collaborative research initiatives that team investigators from top academic research centers and focuses their talents on harnessing the power of the immune system to conquer cancer.
Contact Information
Contact info
Phone
(800) 99-CANCER (800-992-2623)
Fax
(212) 832-9376
Address
Cancer Research Institute National Headquarters One Exchange Plaza 55 Broadway, Suite 1802 New York, NY 10006